Management of brain-heart multimorbidity: a clinical practice guideline.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Edwards Jodi D, Li Zhe, McFarlane Philip, Rabi Doreen M, Gilbert Jeremy, Bajaj Harpreet S, MacIntosh Bradley J, Bittman Jesse, Feldman Ross D, Dresser George, Terenzi Kristin, Swartz Rick, Gabor Jonathan, Pearson Glen J, Selby Peter, Wharton Sean, Warburton Darren E R, Pakhalé Smita, Styra Rima, Baker Brian, Tu Karen, Hawkins Michael, Stone James A, Vaillancourt Tracy, Poon Stephanie, Virani Sean A, Jain Rahul, Jones Peter Hayward, Sandhu Roopinder K, Ganesh Aravind, Andrade Jason G, Stern Sol, Habert Jeffrey, Rivard Léna, Roumeliotis Paul, Udell Jacob A, Campbell Tavis, Bacon Simon L, Trudeau Luc, Keshavjee Karim, Pham Thuy, Cheng Gemma, Lewis Krystina B, Maar Marion, Stacey Dawn, Oldenburg Brian, Dhukai Abida R, Pasricha Sachin V, Sherifali Diana, Racey Megan, Hua-Stewart Diane, Gravel Christopher A, Lewis Meghan, Mehta Sumali, Hill Michael D, Haider Nazia, Lindsay Patrice, Liu Peter, Tobe Sheldon W
Аннотация
METHODS: The guideline development panel comprised an Executive Steering Committee; 10 expert subgroups to develop research questions and draft recommendations for specific brain-heart conditions; an Evidence Review Team to ensure the rigour and consistent application of the methodology; and an Implementation Committee to facilitate uptake of the recommendations by clinicians and into electronic medical records. The McMaster Evidence Review and Synthesis Team supported the literature searches and critical appraisal. A panel of people with lived experience of specific conditions and caregivers provided input on patient values and perspectives throughout the guideline development process. Our consensus process followed the Appraisal of Guidelines for Research and Evaluation II framework. We used an established evidence appraisal approach to determine the level of evidence and strength of each recommendation, and adhered to the Guidelines International Network's principles for managing competing interests.
RECOMMENDATIONS: We developed 11 recommendations for the management of joint brain and heart diseases. Key recommendations include screening for cognitive decline in atrial fibrillation and depression in coronary artery disease; treatment of depression in coronary artery disease, cognitive impairment in hypertension, and dyslipidemia in stroke; and vaccination to prevent stroke, myocardial infarction, and dementia. We also recommend shared decision-making, including the use of evidence-based decision aids, to support patients with heart-brain diseases.
INTERPRETATION: We sought to produce an implementable and actionable guideline for patients with brain and heart comorbidity. It is primarily targeted to primary care providers, but also relevant to help address and individualize subspeciality care and for interprofessional teams caring for patients with joint brain and heart diseases.